| Sarah Egge, | |
|
2011 Broadway St Ste 130, Pearland, TX 77581 | |
| (281) 997-8509 | |
| (888) 449-0039 |
| Full Name | Sarah Egge |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2011 Broadway St Ste 130, Pearland, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073026357 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 107923 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Egge, 3200 Westhill Dr. Apt B, Austin, TX 78704 Ph: (847) 951-2254 | Sarah Egge, 2011 Broadway St Ste 130, Pearland, TX 77581 Ph: (281) 997-8509 |
News Archive
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that the Company has received approval for its request filed with the U.S. Food and Drug Administration for Humanitarian Use Device designation for its biopolymer scaffolding product.
A team of UK-based scientists has developed and validated a DNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that encodes both spike receptor-binding domain (RBD) and nucleocapsid of the virus as vaccine immunogens.
Researchers at The University of Texas MD Anderson Cancer Center have identified molecular and cellular characteristics of anti-CD19 CAR T cell infusion products associated with how patients with large B-cell lymphoma (LBCL) respond to treatment and develop side effects.
Indivior PLC today announced top-line results from its phase 3 clinical trial of RBP-7000, an investigational drug in development for the treatment of schizophrenia. In this pivotal study, both doses of RBP-7000 tested, 90 mg and 120 mg administered once-monthly, met the primary endpoint with statistically and clinically significant reductions in the symptoms of acute schizophrenia over an 8-week treatment period.
› Verified 4 days ago
Paul T Guerra, M.ED, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2011 Broadway St Ste 130, Pearland, TX 77581 Phone: 281-997-8509 | |
Senedra Green, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2011 Broadway St Ste 130, Pearland, TX 77581 Phone: 281-997-8509 Fax: 888-449-0039 | |
Cybil Downs, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2011 Broadway St Ste 130, Pearland, TX 77581 Phone: 281-997-8509 Fax: 888-449-0039 | |
Chelsea Nguyen, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13806 Granite Manor Ln, Pearland, TX 77584 Phone: 409-332-1411 | |
Katrina Belton Williams, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13204 Indigo Creek Ln, Pearland, TX 77584 Phone: 340-800-1613 Fax: 832-288-2802 | |
Carrie Mella, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2011 Broadway St Ste 130, Pearland, TX 77581 Phone: 281-997-8509 Fax: 888-449-0039 | |
Anna Dalton, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2011 Broadway St Ste 130, Pearland, TX 77581 Phone: 281-997-8509 |